ArticleJournal of managed care & specialty pharmacy2025
Tolebrutinib for secondary progressive multiple sclerosis: A summary from the Institute for Clinical and Economic Review's California Technology Assessment Forum.
Shahariar Mohammed Fahim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.